Ernest Lau, a cardiologist at the Royal Victoria Hospital in Belfast, Ireland, was one of the first doctors to identify a defect in St. Jude Medical Inc.’s Riata that led to its recall in 2011. Now Lau is telling colleagues it’s time to embrace the company’s updated device.
Boston Scientific Corp.’s study of a heart device to reduce stroke risk, slated for presentation at a medical heart meeting this weekend, is under review after the company said only limited data about the product’s safety would be released.
St. Jude Medical Inc.’s device to plug openings in the heart after a stroke failed to definitively prevent repeat incidents in patients under age 60 compared with non-surgical drug treatment, two studies found.
Edwards Lifesciences Corp.’s Sapien device replaces damaged aortic heart valves as well as surgery, without cracking open the chest or triggering higher rates of stroke or death after two years, a company-funded study found.